Abstract
Oncology drug discovery and proper conduct of cancer clinical trials are essential to our battle against cancer. According to a 2015 Center for Disease Control and Prevention (CDC) report, the expected cancer cases and deaths in 2020 are 1.9 million and 630,000. While the world is fighting COV-19 pandemic, it is also important to be more creative than ever to continue anti-cancer drug development in a safe manner - without exposing cancer patients to unnecessary COVID-19 risks while maintaining the integrity of cancer clinical trials.
| Original language | American English |
|---|---|
| Journal | |
| State | Published - Apr 20 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Disciplines
- Biostatistics
- Environmental Public Health
- Epidemiology
- Public Health
Fingerprint
Dive into the research topics of 'Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver